Abstract:BACKGROUND Melasma is a common pigmentary disorder that affects all skin types but is seen more in individuals with Fitzpatrick skin type IV to VI. Safe and effective treatment options for melasma need to be explored. Already proven effective for the treatment of pigmentary disorders, lasers have been used to treat melasma in recent years.OBJECTIVE To evaluate the efficacy and safety profile of a 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet (QS Nd:YAG) laser in the treatment of melasma.METHODS Fifty patients were recruited for this study (47 female; 3 male). All were treated using the 1,064-nm QS Nd: YAG laser at low energy levels weekly for nine sessions. Follow-up was done 3 months after the final laser session, and recurrence rates were evaluated. Digital photographs were taken and the melanin index (MI) measured before each treatment visit and after the final treatment. Melasma Area and Severity Index (MASI) scores were evaluated for all of the patients. Patients were required to evaluate their satisfaction at the end of the nine treatments. We also used a confocal laser scanning microscope (CLSM) for several patients to investigate pathologic changes at baseline, after the treatments, and at the time of recurrence. Statistical analysis was performed to evaluate clinical response and factors related to the therapeutic outcome.RESULTS Mean MI decreased 35.8%, from 70.0 at baseline to 44.9 after the treatment (p < .001). Mean MASI scores decreased 61.3% after therapy (from 10.6-4.1, p < .001); 70% of patients had more than a 50% decrease in their MASI values, and 10% had 100% clearance. Recurrence rate at the 3-month follow-up was 64%. CLSM findings indicated less melanin in the treated regions, although it increased at recurrence. Multiple linear regression indicated that the therapeutic outcome depended on disease severity at baseline (p = .001, R = 0.494). Minimal adverse events were observed during the study.CONCLUSIONS The 1,064-nm QS Nd: YAG laser is an effective and safe treatment for melasma, although recurrence rates remain high, and further adjunctive therapy needs to be explored to prevent this recurrence.

1064 Nm Nd:YAG Laser Treatment of Melanocytic Nevi of the External Auditory Canal: a Retrospective Study of 15 Cases

Aesthetic Removal Of Large Melanocytic Nevi Using Co2 Lasers With A Programmed 4-Step Approach

Clinical efficacy of long-pulsed 1 064 nm Nd:YAG laser in the treatment of spider nevus

A Retrospective Study on the Characteristics of Treating Nevus of Ota by 1064-Nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser

Clinical efficacy of long-pulsed 1064 nm Nd:YAG laser in the treatment of spider nevus

Induction of Melasma by 1064-Nm Q-Switched Neodymium: Yttrium-Aluminum-Garnet Laser Therapy for Acquired Bilateral Nevus of Ota-Like Macules (hori Nevus): A Study on Related Factors in the Chinese Population

Erbium: YAG laser treatment efficacy and association with histologic features for giant congenital melanocytic nevi management

Novel 532‐nm Q‐switched Nd: YAG laser for the treatment of melasma and rejuvenation: a prospective, randomized controlled comparison with 1,064‐nm Q‐switched Nd: YAG laser

Nd:YAG Laser Therapy for Deeper Venous Malformation in the Head and Neck Through Surgical Exposure of the Lesions: a Consecutive Report of 108 Cases

Treatment Of Congenital Melanocytic Nevi In The Eyelid And Periorbital Region With Ablative Lasers

NdYAG Laser Therapy of Benign Laryngeal Lesions

Comparison of the efficacy and safety of a 730‐nm picosecond titanium sapphire laser and a 1064‐nm picosecond neodymium yttrium aluminum garnet laser for the treatment of acquired bilateral nevus of Ota‐like macules: A split‐face, evaluator‐blinded, randomized, and controlled pilot trial

[Noninvasive Laser Therapy for Skin Superficial Venous Malformations with Long Pulsed Nd:YAG Laser].

Efficacy and Safety of Q-Switched 1,064-Nm Neodymium-Doped Yttrium Aluminum Garnet Laser Treatment of Melasma

High-fluence 1064nm Q-switched Nd:YAG laser treatment for ectopic Mongolian spot

Microinvasive Nd : Yag Laser Therapy of Early Glottic Carcinoma and Its Effect on Soluble Interleukin-2 Receptor, Interleukin-2, and Natural Killer Cells

Pilot Study to Demonstrate Improvement in Skin Tone and Texture by Treatment with a 1064 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser

The Mid-term Efficacy of Ablative Lasers in Treating Children’s Congenital Melanocytic Nevi of Eyelids and Periorbital Areas

The observation of effects with Q-switched Nd:YAG laser on 165 cases of naevus fuscocaeruleus zygomaticus

Beneficial Effects of Treatment with Low‐Fluence 755‐nm Q‐Switched Alexandrite Laser for Nevus of Ota

Comparison of 755‐nm picosecond alexandrite laser versus 1064‐nm Q‐switched Nd:YAG laser for melasma: A randomized, split‐face controlled, 2‐year follow‐up study